Scholars Central

CommentaryPublished 3 May 2023

Novel pharmacological developments for the treatment of diabetic kidney disease

Authors: Emma Johnston, Eric Dansin

Journal of Kidney Treatment and Diagnosis

Volume 6 · Issue 1 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In addition to being one of the main consequences of diabetes, Diabetic Kidney Disease (DKD) is also the main cause of End Stage Renal Disease (ESRD). The incidence and progression of DKD have long been important clinical issues that raise morbidity and death while severely impairing people's quality of life. DKD can progress more slowly if blood sugar, blood pressure, blood lipids, and lifestyle factors are managed. A growing number of new drugs are being developed based on extensive research into the pathological and molecular causes of DKD. Examples include Sodium Glucose Cotransporter 2 (SGLT2) inhibitors, Glucagon Like Peptide-1 (GLP-1) inhibitors, and Dipeptidyl Peptidase-4 (DPP-4) inhibitors, all of which have demonstrated good clinical efficacy. Aside from that, there are a number of recently created medications, such as Protein Kinase C (PKC) inhibitors, Advanced Glycation End product (AGE) inhibitors, aldosterone receptor inhibitors, Endothelin Receptor (ETR) inhibitors, Transforming Growth Factor- (TGF-) inhibitors, Rho Kinase (ROCK) inhibitors, and others, that have shown promise in animal or clinical trials for the treatment of DKD.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Kidney Treatment and Diagnosis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Kidney Treatment and Diagnosis
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Emma Johnston”
  • BylineArticles whose byline prints “Eric Dansin”